RSWM
CUE icon

Robertson Stephens Wealth Management’s Cue Biopharma CUE Stock Holding History

Robertson Stephens Wealth Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$110K Hold
15,950
– – ﹤0.01% 597
2025
Q4 		$146K Hold
15,950
– – ﹤0.01% 614
2025
Q3 		$344K Hold
15,950
– – 0.01% 423
2025
Q2 		$326K Hold
15,950
– – 0.01% 440
2025
Q1 		$436K Hold
15,950
– – 0.02% 386
2024
Q4 		$522K Hold
15,950
– – 0.02% 352
2024
Q3 		$362K Hold
15,950
– – 0.01% 492
2024
Q2 		$593K Hold
15,950
– – 0.03% 306
2024
Q1 		$904K Hold
15,950
– – 0.05% 248
2023
Q4 		$1.26M Hold
15,950
– – 0.08% 199
2023
Q3 		$1.1M Hold
15,950
– – 0.07% 195
2023
Q2 		$1.75M Hold
15,950
– – 0.12% 142
2023
Q1 		$1.71M Hold
15,950
– – 0.13% 142
2022
Q4 		$1.36M Hold
15,950
– – 0.13% 148
2022
Q3 		$1.07M Hold
15,950
– – 0.11% 147
2022
Q2 		$1.19M Hold
15,950
– – 0.11% 144
2022
Q1 		$2.33M Hold
15,950
– – 0.2% 97
2021
Q4 		$5.41M Hold
15,950
– – 0.46% 47
2021
Q3 		$6.97M Hold
15,950
– – 0.79% 29
2021
Q2 		$5.57M Hold
15,950
– – 0.67% 33
2021
Q1 		$5.84M Sell
15,950
-183
-1% -$75.3K 0.93% 24
2020
Q4 		$6.05M Hold
16,133
– – 1.27% 19
2020
Q3 		$7.28M Buy
+16,133
New +$9.3M 1.79% 14

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $1.84B AUM 19.34% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

Robertson Stephens Wealth Management's CUE Position: Q1 2026 in Review

Robertson Stephens Wealth Management held its Cue Biopharma (CUE) position steady in Q1 2026 at 15,950 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #597.

Robertson Stephens Wealth Management first reported a position in CUE in Q3 2020 and has held it in 23 quarters since. The position peaked at $7.28M in Q3 2020. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • Robertson Stephens Wealth Management held 15,950 shares of Cue Biopharma worth $110K as of Q1 2026.
  • Robertson Stephens Wealth Management left its Cue Biopharma share count unchanged in Q1 2026.
  • Cue Biopharma made up ﹤0.01% of Robertson Stephens Wealth Management's portfolio in Q1 2026, its #597 holding.
  • Robertson Stephens Wealth Management first reported a position in Cue Biopharma in Q3 2020 and has held it in 23 quarters since.
  • Robertson Stephens Wealth Management's Cue Biopharma position peaked at $7.28M in Q3 2020.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.